Why we focus on product-system fit

A medicine or device does not reach a patient through a market. It reaches them through a system: payers, clinicians, guideline committees, patient groups, procurement, hospital pharmacies, referral networks. Each has its own incentives and its own view of risk. A market asks whether people want the product. A system asks whether the people around the product are willing and able to let it through. A product can pass the first test and still fail the second.

We don't replace product-market fit. We complete it. We study the system your product has to move through, measure how ready it is, and show what it takes to get it ready. That means mapping the real stakeholder field — not only the obvious names — across payers, clinicians, guideline committees, patient groups, procurement and referral networks. It also means capturing perception, not just position: surfacing how each stakeholder sees the product, including the belief and emotion behind their stated view, so the real reason for a decision sits alongside the stated one.

We then sort what would move the system: what stakeholders value, what they fear, what would move them and what holds them back — and what would have to change for adoption to follow. Finally, we baseline and track readiness so a hidden risk becomes a shared target that teams can act on over time.

The payoff is threefold: a shared, board-ready picture of the system a product has to move through; a readiness baseline that turns hidden adoption risk into a specific target; and earlier visibility of what would have to change for approval to turn into access, and access into use.